Effect of Eicosapentaenoic acid on adequate statin therapy in patients with coronary artery disease. Prospective randomized trial

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2012
INTERVENTION: Add oral EPA 1800 mg daily on the ordinary statin treatment. Ordinary statin treatment. CONDITION: Coronary artery disease PRIMARY OUTCOME: Change in flow mediated dilation. SECONDARY OUTCOME: Change in Lipid profiles. INCLUSION CRITERIA: The inclusion criteria were; 1. Patients with established coronary artery disease. 2. ALL patients received adequate statin treatment and LDL‐Cholesterol was controlled less than 100 mg/dl. 3. Patients had endothelial dysfunction defined as FMD <6%.
Epistemonikos ID: 12f806a9c9765c26846377e77011f53dcaa048e8
First added on: Aug 22, 2024